whitepaper

App note: Struggling with ERK phosphorylation in GPCR research?

Posted: 1 September 2016 | | No comments yet

This short, easy-to-read Application Note goes over the background and basics of ERK signaling in multiple GPCR models…

ERK1/2 is an important GPCR signaling effector. Our Advanced Phospho-ERK1/2 (Thr202/Tyr204) kit accurately quantifies ERK phosphorylation in response to GPCR stimulation.

This short, easy-to-read Application Note goes over the background and basics of ERK signaling in multiple GPCR models. See our data on commonly used cell types:

  • Immortalized cell lines
  • Cancer cell lines
  • Tumor patient derived cell lines

This application note is restricted - login or subscribe free to access

Drug Target Review - Issue 2 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Related organisations